Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -30.33% is 99% above its 2-year average of -5492.00%, near the high end of its 2-year range (-12911.93%–-30.33%).
As of the fiscal period ended Monday, December 31, 2007. 98.30% above its 12-month average of -1782.03%.
Annual fiscal-year EBITDA margin; no daily interpolation. Historical series through 2007-12-31.
EBITDA MARGIN
-30.33%
EBITDA MARGIN AVG TTM
-1782.03%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+98.30%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Oruka Therapeutics, Inc.
Market Cap
$4.84B
EBITDA Margin
-30.33%
TTM Avg
-1782.03%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.85B
EBITDA Margin
-8718.32%
TTM Avg
-5172.73%
3Y Avg
-3124.55%
5Y Avg
-2649.58%
Market Cap
$4.90B
EBITDA Margin
0.40%
TTM Avg
-9.29%
3Y Avg
-59.36%
5Y Avg
-227.69%
Market Cap
$4.70B
EBITDA Margin
5.54%
TTM Avg
4.34%
3Y Avg
-4.50%
5Y Avg
-6.75%
Market Cap
$4.65B
EBITDA Margin
7.23%
TTM Avg
7.47%
3Y Avg
7.86%
5Y Avg
7.54%
Market Cap
$4.65B
EBITDA Margin
9.15%
TTM Avg
-7.04%
3Y Avg
-33.99%
5Y Avg
-33.99%
Market Cap
$5.08B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | $4.84B | -30.33% | -1782.03% | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.85B | -8718.32% | -5172.73% | -3124.55% | -2649.58% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | 0.40% | -9.29% | -59.36% | -227.69% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 5.54% | 4.34% | -4.50% | -6.75% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 7.23% | 7.47% | 7.86% | 7.54% |
| BillionToOne, Inc. (BLLN)vs › | $4.65B | 9.15% | -7.04% | -33.99% | -33.99% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.08B | 21.06% | 20.50% | 18.63% | 16.67% |
| Erasca, Inc. (ERAS)vs › | $5.08B | N/A | N/A | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.18B | -395.82% | -536.17% | -471.62% | -471.62% |
Gross Margin
0.0%
EBITDA Margin
-30.3%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2007-12-31 | -30.33% |
| 2006-12-31 | -3533.74% |
| 2005-12-31 | -12911.93% |
